Back to search
Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease trials you may qualify forThe main objective of this study is to evaluate the efficacy of satralizumab compared with placebo based on time from randomization to the first occurrence of a…
This study is an open-label, exploratory, prospective clinical trial with dose escalation(according to "3+3" design), to evaluate the safety and tolerability of…
The RECLAIM study aims to gather a centralized and harmonized dataset, enabling the secondary use of data for building AI-based models that will support diagnos…
The MESO7 study is a prospective observational research project designed to investigate the mechanisms of resilience and neurodegeneration in neurological disea…
Anti-myelin oligodendrocyte glycoprotein-IgG-associated disorders (MOGAD) is a rare inflammatory autoimmune disease. In addition, since the international MOGAD…
The goal of this study is to assess the frequency of genetic polymorphisms of the FCG3A in a cohort of Italian patients affected by neuromyelitis optica spectru…
The purpose of the study is to evalute the efficacy, safety and tolerability of rozanolixizumab for treatment of adult participants with myelin oligodendrocyte…
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) is an inflammatory demyelinating disorder of the central nervous system characterized by…
Neurological Autoimmune Diseases (NADs) are disorders caused by abnormal immune system attacks on neural tissues, affecting multiple systems including the centr…